No mutations were identified.
|
|
- Sherilyn Sanders
- 6 years ago
- Views:
Transcription
1 Hereditary High Cholesterol Test ORDERING PHYSICIAN PRIMARY CONTACT SPECIMEN Report date: Aug 1, 2017 Dr. Jenny Jones Sample Medical Group 123 Main St. Sample, CA Kelly Peters Sample Medical Group 123 Main St. Sample, CA Type: Saliva Barcode: Collected: Jul 15, 2017 Received: Jul 17, 2017 No mutations were identified. This means no pathogenic or likely pathogenic mutations associated with Familial Hypercholesterolemia (FH) were identified in any of the genes analyzed. FH is a hereditary disorder associated with very high levels of cholesterol (hypercholesterolemia) at an early age, specifically a type of cholesterol called LDL-C. High cholesterol can impact your risk of coronary heart disease, which can lead to heart attack and stroke. NOTES ABOUT YOUR RESULT A negative test result for mutations that cause FH does not mean that you don t have high cholesterol or a clinical diagnosis of FH. Environment and lifestyle, as well as family history without a known genetic link, can have a large influence on your cholesterol. Work with your healthcare provider to understand your cholesterol and manage it if needed. GENES ANALYZED The genes below were analyzed, and no pathogenic or likely pathogenic mutations associated with Familial Hypercholesterolemia were identified. Please see the test methodology and limitations section for additional information. APOB, LDLR, PCSK9 REVIEWED BY Tom Sample, MD, Pathologist Date 1 / 8
2 Risk and Family Information LIFETIME RISK among US men Average risk among US men to develop coronary heart disease in their lifetime. Risk may vary because of factors such as diet and physical activity level, among others. CORONARY HEART DISEASE 1 60% 45% Normal cholesterol Borderline cholesterol High cholesterol 30% 15% 0% Risk at age: FAMILY Consider sharing your results with relatives who may also benefit from genetic testing. A few key points to remember: Your negative result significantly lowers the chance that you have an inherited mutation associated with Familial Hypercholesterolemia (FH). It is still possible for your relatives to have a mutation that you did not inherit. They may benefit from their own genetic testing, especially those who have had high cholesterol. If any of your relatives has a mutation, there is a 50% chance that their siblings and children also have the same mutation. A father and mother are equally likely to pass on a mutation. Sons and daughters are equally likely to inherit a mutation if one of their parents has it. If you learn that a relative of yours has a mutation, contact a Color genetic counselor to learn how that information may impact your risk assessment and interpretation of results. 1 Lloyd-Jones DM, Wilson PW, Larson MG, et al. Lifetime risk of coronary heart disease by cholesterol levels at selected ages. Arch Intern Med. 2003;163(16): / 8
3 Know Your Screening Guidelines Below is a summary of the current screening guidelines from the American Heart Association (AHA). These guidelines are for men with the same risk of coronary heart disease as the average US man. Your healthcare provider may use the AHA Guidelines to help create a customized screening plan for you. CORONARY HEART Starting at age 20: DISEASE 2 Blood pressure checked at each regular healthcare visit or at least once every 2 years Cholesterol levels checked every four to six years Weight and Body Mass Index (BMI) checked at each regular healthcare visit Waist circumference checked as needed to help evaluate cardiovascular risk Discussion of risk factors such as smoking, physical activity, and diet at each regular healthcare visit Starting at age 45: Blood sugar (glucose) test every three years These recommendations may change if you have an elevated risk for heart attack or stroke due to other risk factors. GENERAL HEART HEALTH RECOMMENDATIONS FOR ALL INDIVIDUALS 3 Don t smoke and avoid second-hand smoke Treat high blood pressure if you have it Eat foods that are low in saturated fat, trans fat, sodium (salt) and added sugars Be physically active Reach and maintain a healthy weight Control your blood sugar if you have diabetes Get regular medical check-ups Take medicine as prescribed 2 Goff DC, Lloyd-jones DM, Bennett G, et al ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S Eckel RH, Jakicic JM, Ard JD, et al AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S / 8
4 Common Questions GENERAL QUESTIONS What does a negative test result mean? A negative result means no pathogenic or likely pathogenic genetic variants associated with Familial Hypercholesterolemia (FH) were identified in any of the genes analyzed. This result does not mean you don t have high cholesterol or a clinical diagnosis of FH, and does not eliminate your risk of developing coronary heart disease. You may still be at increased risk of high cholesterol due to other factors, mutations not detected by current technology, or mutations in other genes. Does this result mean I m not at risk of developing high cholesterol? No, the absence of mutations does not mean that you will not develop high cholesterol. Because cholesterol levels can be affected by many non-genetic factors, a negative result does not mean high cholesterol can t happen. Eating foods high in saturated fats and cholesterol increase the levels of cholesterol, which increases the chances of coronary heart disease. The risk of coronary heart disease is higher in people who have high cholesterol, are overweight, are not physically active, smoke and drink excessive amounts of alcohol, and in people with diabetes. Factors we cannot control that affect cholesterol levels include age, sex, and other genetic factors. Older individuals typically have higher levels of cholesterol and a higher risk of heart disease. In addition, not all of the genes related to having high cholesterol levels are known or included on the Color test. You should continue to follow the screening and prevention advice of your healthcare team, or schedule an appointment with a Color genetic counselor if you have questions. Who will see these test results? Your results are available to you and the healthcare provider who ordered your test, as well as any additional healthcare providers you designated. Your results will not be sent by Color to your insurance company, employer, or any other healthcare provider without your explicit request. Should I share my results with my healthcare provider? Color recommends you share your results with your provider. Sharing your results allows your provider to guide you to appropriate resources and discuss tailored options for screening and monitoring of cholesterol levels. Are there any protections against discrimination based on these results? In 2008, a federal law called the Genetic Information Non-Discrimination Act (GINA) was passed. Under the terms of GINA, medical insurance companies and employers are prohibited from discriminating against individuals on the basis of genetic information. GINA defines genetic information as including not only genetic test results, but also family history, and the fact that genetic testing occurred. The terms of GINA specify that insurance companies cannot raise rates, cancel a plan, or determine eligibility because of genetic testing. Employers also are prohibited from making hiring, firing, or promotion decisions based on genetic testing. The terms of GINA carry exceptions. For example, an exception might include employers with fewer 4 / 8
5 GENERAL QUESTIONS (Continued) than 15 employees and those with military insurance. Additionally, GINA does not extend to life, disability, or long-term insurance companies. Some states may have protections regarding discrimination from these types of insurance. Individuals may consider purchasing these policies prior to undergoing genetic testing. ABOUT FAMILY What do my results mean to my relatives and do any of them need to consider genetic testing? Though you do not carry a mutation associated with FH, it is possible that your relatives have one that you did not inherit. The only way for them to know whether or not they have such a mutation is for them to undergo genetic testing. Genetic testing can be particularly informative for individuals in the family who have high cholesterol. Please schedule an appointment with a Color genetic counselor for specific recommendations about testing tailored to your family. Should I talk with my relatives about my result? You are encouraged to share these results with your relatives. Knowing this information may help them decide whether genetic testing is right for them. Relatives with high cholesterol may especially find this information useful. However, keep in mind that not everyone wants to know their genetic status and genetic testing is a personal decision. 5 / 8
6 TEST METHODOLOGY AND LIMITATIONS Methodology This test is designed to assess clinically relevant mutations in genes associated with Familial Hypercholesterolemia. Genomic DNA is extracted from a saliva or peripheral blood sample using standard methods. For the genes analyzed, Next Generation Sequencing libraries compatible with the Illumina platform are generated and enriched via a custom designed Agilent SureSelect bait library. DNA fragments enriched from these genes are retrieved and analyzed using 2x150 paired-end sequencing with an Illumina NextSeq 500 instrument. After alignment to reference genome GRCh37.p12 (hg19), low quality and duplicate reads are removed and variants are identified using the GATK Haplotypecaller. This test detects single nucleotide substitutions (SNV), small insertions and deletions (indels) in the DNA coding sequences, nearby flanking regions (+/- 20bp) and known splice regions in the genes targeted by the Color panel. In addition, copy number variations (CNVs), large insertions and inversions overlapping coding exons, are reported. The Color test has >20X coverage for 100% of regions in our reportable range. The median coverage across our samples is >250X and our minimum acceptance criteria for depth is: >99% at >50X and 100% at 20X. Any exceptions to this are noted in the Limitations section. Variants are classified according to the standards and guidelines for sequence variant interpretation of the American College of Medical Genetics and Genomics (ACMG). Variant classification categories include pathogenic, likely pathogenic, variant of uncertain significance (VUS), likely benign, and benign. All variants are evaluated by a board certified medical geneticist or pathologist. Identified likely benign and benign variants are not reported. The presence of a VUS is always reported, and the details are available upon request. All VUS and likely pathogenic variants are reviewed bi-annually for updates in the scientific literature. As part of the Color service, we will attempt to recontact the provider and/or the person that was tested if any reported variant s classification changes. Clinically actionable variants (i.e. likely pathogenic and pathogenic) are confirmed using an alternative technology (Sanger sequencing, acgh or MLPA) in compliance with Color s internal protocols and relevant ACMG guidelines. For SNVs and indels, a confidence model (color.com/ variantconfidence) is used to identify high and low confidence variants. Low confidence variants, and structural variants (CNVs, insertions and inversions) are confirmed using an alternative technology. High confidence, clinically actionable variants that have been independently confirmed at least three times will not be submitted for further secondary confirmation. High confidence VUSs are reported without secondary confirmation. This test was developed and its performance characteristics determined by, a clinical laboratory accredited by the College of American Pathologists (CAP) and certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high-complexity testing (CAP # CLIA #05D ). This test has not been cleared or approved by the United States Food and Drug Administration (FDA). The FDA does not require this test to go through premarket FDA review. This test is used for clinical purposes. It should not be regarded as investigational or for research. Genes APOB*, LDLR**, PCSK9* 6 / 8
7 TEST METHODOLOGY AND LIMITATIONS (Continued) * Please see the Limitations section for more information. ** The promoter region is analyzed for CNVs. In addition, a small region of the promoter (LDLR, Chr19: ) is also analyzed for the presence of clinically relevant SNVs and indels. Limitations This test aims to detect all clinically relevant variants within the genes analyzed (defined above). The majority of these genes are assessed for variants within all coding exons (+/- 20bp in the nearby flanking regions). For PCSK9 gene exon 8, only the first 7bp of intron 8 are analyzed. In APOB, exon 1 is not analyzed. For the LDLR promoter region, the detection of deletions, duplications, and complex structural rearrangements may be limited. This test is not designed to detect chromosomal aneuploidy or complex rearrangements such as translocations. It also does not reliably detect mosaicism. The sensitivity to detect deletions and duplications in the range of bp, as well as those which deletion/duplication do not overlap more than 250bp of contiguous coding sequence, may be reduced. The presence of a large insertion may interfere with the chemistry used to target the genes of interest, which could decrease the detection sensitivity. In addition, the sequence and identity of a large insertion may not be completely resolved. Inversions including at least one coding exon will be detected only if the breakpoints are covered by the Color test. The sensitivity to detect variants in the vicinity of homopolymer regions may be reduced. Color only reports findings within the genes that are on the panel. It is important to understand that there may be variants in those genes that current technology is not able to detect. Additionally, there may be genes associated with Familial Hypercholesterolemia whose clinical association has not yet been definitively established. The test may therefore not detect all variants associated with Familial Hypercholesterolemia. Additionally, in the unlikely event a variant is detected that is associated with a disorder other than Familial Hypercholesterolemia, this information will not be included in the report. Genetic counseling and/or physician consultation may be warranted to ensure complete understanding of your test results. In very rare cases, such as circulating hematolymphoid neoplasm, allogeneic bone marrow transplant, or recent blood transfusion (within 7 days of testing), the results of germline DNA analysis may be complicated by somatic and/or donor mutations. DNA quality may be affected if a participant has received chemotherapy within the last 120 days. Disclaimers Color implements several safeguards to avoid technical errors, such as 2-dimensional barcoding and barcode scanning at several steps throughout the sequencing process. Color is not responsible for errors in specimen collection, transportation, and activation or other errors made prior to receipt at our laboratory. Due to the complexity of genetic testing, diagnostic errors, although rare, may occur due to sample mix-up, DNA contamination, or other laboratory operational errors. In addition, poor sample DNA quality and certain characteristics inherent to specific regions of an individual s genomic DNA may limit the accuracy of results in those regions. In the absence of an identified pathogenic or likely pathogenic mutation, standard risk models may be employed to determine potential risk of Familial Hypercholesterolemia and guidelines 7 / 8
8 TEST METHODOLOGY AND LIMITATIONS (Continued) displayed on this report. All risk estimation is approximate, sometimes cannot be specifically calculated, and is based on previously analyzed cohorts. Additionally, risk estimation may be incorrect if inaccurate personal or family history is provided. An elevated risk for Familial Hypercholesterolemia is not a diagnosis and does not guarantee that a person will develop the disease. Contact us free of charge at (844) with any questions. 8 / 8
No mutations were identified.
Hereditary Heart Health Test DOB: May 25, 1977 ID: 123456 Sex: Female Requisition #: 123456 ORDERING PHYSICIAN Dr. Jenny Jones Sample Medical Group 123 Main St. Sample, CA SPECIMEN Type: Saliva Barcode:
More informationA pathogenic mutation was identified in the BRCA1 gene.
Hereditary Cancer Risk Test ORDERING PHYSICIAN Dr. Jenny Jones Sample Medical Group 123 Main St. Sample, CA SPECIMEN Type: Saliva Barcode: 223 234234 2343 Collected: Apr 13, 2016 Received: Apr 14, 2016
More informationMEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)
Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Ordering Information Acceptable specimen types: Fresh blood sample (3-6 ml EDTA; no time limitations associated with receipt)
More informationGenetics and Genetic Testing for Autism:
STAR Training 2/22/2018 Genetics and Genetic Testing for Autism: Demystifying the Journey to Find a Cause Alyssa (Ah leesa) Blesson, MGC, CGC Certified Genetic Counselor Center for Autism and Related Disorders
More informationGeneticsNow TM. A Guide to Testing Hereditary Conditions in Women & Men. Patient & Physician Information
GeneticsNow TM A Guide to Testing Hereditary Conditions in Women & Men Patient & Physician Information How can BRCA status affect your health? Everyone has BRCA1 and BRCA2 genes. However, sometimes the
More informationCommonly asked questions about genetic testing for hereditary cancer
Commonly asked questions about genetic testing for hereditary cancer Understanding genetic testing for hereditary cancer What is hereditary cancer? In some cases, cancer is caused by genetic changes (or
More informationRole of Genetic Counseling in FH: What Referring Physicians Need to Know. Amy C. Sturm, MS, CGC September 21, 2013
Role of Genetic Counseling in FH: What Referring Physicians Need to Know Amy C. Sturm, MS, CGC September 21, 2013 Disclosures Nothing to disclose. 2 Introduction to the topic Who are genetic counselors?
More informationA Guide to Genetics and Health
2 D o e s i t R u n i n t h e Fa m i ly? A Guide to Genetics and Health BEAUMONT CANCER GENETICS PROGRAM COVENANT COMMUNITY HEALTH CENTER Contents Why is genetics important to my family and me? What makes
More informationMEDICAL GENOMICS LABORATORY. Peripheral Nerve Sheath Tumor Panel by Next-Gen Sequencing (PNT-NG)
Peripheral Nerve Sheath Tumor Panel by Next-Gen Sequencing (PNT-NG) Ordering Information Acceptable specimen types: Blood (3-6ml EDTA; no time limitations associated with receipt) Saliva (OGR-575 DNA Genotek;
More informationBRCAnowTM It s Your Decision
Hereditary Breast and Ovarian Cancer BRCAnowTM It s Your Decision Patient & Physician Information What is BRCA? The breast cancer genes BRCA1 and BRCA2 are found within an individual s normal genetic makeup;
More informationDNA Basics. We are all made up of cells. Cells contain DNA, or instructions to tell our bodies how to work.
DNA Basics We are all made up of cells. Cells contain DNA, or instructions to tell our bodies how to work. DNA is packaged into structures called chromosomes. Each chromosome contains many genes and each
More informationSequencing. Deletion/Duplication Analysis. How Does Genetic Testing for Cancer Work?
There are several steps involved with genetic testing for cancer predisposition. The first step would be to meet with a specialist, such a genetic counselor, who can assess your medical and family history
More informationGenetic Counseling & Testing. Courtney Eddy, MS, LCGC, MT(ASCP) Licensed & Certified Genetic Counselor
Genetic Counseling & Testing Courtney Eddy, MS, LCGC, MT(ASCP) Licensed & Certified Genetic Counselor What will you hear today? Description of genetic counseling & genetic counselors Description of a typical
More informationMEDICAL GENOMICS LABORATORY. Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG)
Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG) Ordering Information Acceptable specimen types: Blood (3-6ml EDTA; no time limitations associated with
More informationA Guide for Understanding Genetics and Health
2 Does it Run in the Family? A Guide for Understanding Genetics and Health live for life duke Institute for genome sciences & policy Contents Why is genetics important to my family and me? 1 What makes
More informationGENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center
GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center Definitions: DNA: The material found in our cells - the instructions
More informationSNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.
SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: LOSS,
More informationA Guide to Genetics and Health
2 D o e s i t R u n i n t h e Fa m i ly? A Guide to Genetics and Health COMPREHENSIVE COMMUNITY HEALTH CENTERS, INC. Contents Why is genetics important to my family and me? What makes me unique? Tell me
More informationWHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.
WHAT IS A GENE? CHROMOSOME GENE DNA A gene is made up of DNA. It carries instructions to make proteins. The proteins have specific jobs that help your body work normally. PROTEIN 1 WHAT HAPPENS WHEN THERE
More informationInformation for You and Your Family
Information for You and Your Family What is Prevention? Cancer prevention is action taken to lower the chance of getting cancer. In 2017, more than 1.6 million people will be diagnosed with cancer in the
More informationGetting to Know the Generation Program s Approach to Disclosing Information about Your Risk for Alzheimer s disease
Getting to Know the Generation Program s Approach to Disclosing Information about Your Risk for Alzheimer s disease The Generation Program is made up of two clinical trials: Generation Study 1 and Generation
More informationCHROMOSOMAL MICROARRAY (CGH+SNP)
Chromosome imbalances are a significant cause of developmental delay, mental retardation, autism spectrum disorders, dysmorphic features and/or birth defects. The imbalance of genetic material may be due
More informationFIRST NAME MI LAST NAME BIRTH DATE (MM/DD/YYYY) GENDER. Name of person previously tested and relationship:
REQUEST FOR GERMLINE BAP1TESTING Please provide the following information. We cannot perform your test without ALL of this information. PLEASE PRINT ALL ANSWERS PATIENT INFORMATION* FIRST NAME MI LAST
More informationSNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.
SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: GAIN,
More informationA Guide for Understanding Genetics and Health
2 Does it Run in the Family? A Guide for Understanding Genetics and Health INTERMOUNTAIN HEALTHCARE Contents Why is genetics important to my family and me? 1 What makes me unique? 2 Tell me more about
More informationThe benefit of knowing
The benefit of knowing Genetic testing for familial hypercholesterolemia (FH) A patient support guide 2 Does high cholesterol run in your family? In some families, high cholesterol is caused by familial
More informationWHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.
WHAT IS A GENE? CHROMOSOME E GEN DNA A gene is made up of DNA. It carries instructions to make proteins. The proteins have specific jobs that help your body work normally. PROTEIN 1 WHAT HAPPENS WHEN THERE
More informationTumorNext-HRD with OvaNext: Paired Germline and Tumor Analyses of Genes Involved in
SAMPLE REPORT Ordered By Contact ID:1251298 Example, Doctor, MD MOCKORG44 (10829) 123 Somewhere LaneSuite 4 Heaven NV 78872 US Ph:123-123-1234 Fx:123-123-1223 Org ID:8141 Normal Specimen Accession #: 00-086947
More informationA Guide for Understanding Genetics and Health
2 Does it Run in the Family? A Guide for Understanding Genetics and Health brookdale hospital and medical center Contents Why is genetics important to my family and me? 1 What makes me unique? 2 Tell me
More informationMovement Disorders Requisition Form
Movement Disorders Requisition Form The University of Chicago Genetic Services Laboratories 5841 South Maryland Avenue, Room G701/MC0077, Chicago, IL 60637 Toll Free: 888.824.3637 Local: 773.834.0555 Fax:
More informationEpilepsy Genetics Service Kings College Hospital & St Thomas s Hospital, London
Epilepsy Genetics Service Kings College Hospital & St Thomas s Hospital, London Epilepsy Genetics Service Kings College Hospital & St Thomas s Hospital, London Epilepsy Genetics Team Professor Deb Pal
More informationpatient education Fact Sheet
patient education Fact Sheet PFS007: BRCA1 and BRCA2 Mutations OCTOBER 2017 BRCA1 and BRCA2 Mutations Cancer is caused by several different factors. A few types of cancer run in families. These types are
More informationA Guide for Understanding Genetics and Health
2 Does it Run in the Family? A Guide for Understanding Genetics and Health National Council of La Raza Contents Why is genetics important to my family and me? 1 What makes me unique? 2 Tell me more about
More informationA Guide for Understanding Genetics and Health
2 Does it Run in the Family? A Guide for Understanding Genetics and Health u n i v e r s i t y o f o k l a h o m a health sciences center Contents Why is genetics important to my family and me? 1 What
More informationChapter 1 : Genetics 101
Chapter 1 : Genetics 101 Understanding the underlying concepts of human genetics and the role of genes, behavior, and the environment will be important to appropriately collecting and applying genetic
More informationTumorNext-HR D. patient guide. a test for ovarian cancer patients to identify hereditary and tumor-specific mutations
patient guide TumorNext-HR D a test for ovarian cancer patients to identify hereditary and tumor-specific mutations Because knowing can mean personalized treatment and management Germline vs. Tumor Testing
More informationJULY 21, Genetics 101: SCN1A. Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology
JULY 21, 2018 Genetics 101: SCN1A Katie Angione, MS CGC Certified Genetic Counselor CHCO Neurology Disclosures: I have no financial interests or relationships to disclose. Objectives 1. Review genetic
More informationThe Next Generation of Hereditary Cancer Testing
The Next Generation of Hereditary Cancer Testing Why Genetic Testing? Cancers can appear to run in families. Often this is due to shared environmental or lifestyle patterns, such as tobacco use. However,
More informationThe benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide
The benefit of knowing Genetic testing for hereditary cancer A patient support guide Does cancer run in your family? Cancer is more common in some families. Sometimes cancer is caused by a change in a
More informationPatients First. Risk Reduction for Heart and Vascular Disease. High blood cholesterol is one of the major risk factors for heart and vascular disease.
Patient Education HEALTH AND WELLNESS High blood cholesterol is one of the major risk factors for heart and vascular disease. Risk Reduction for Heart and Vascular Disease Risk factors are habits, traits
More informationPerformance Characteristics BRCA MASTR Plus Dx
Performance Characteristics BRCA MASTR Plus Dx with drmid Dx for Illumina NGS systems Manufacturer Multiplicom N.V. Galileïlaan 18 2845 Niel Belgium Table of Contents 1. Workflow... 4 2. Performance Characteristics
More informationSeptember 23, The Role of In Vitro Diagnostic Tests in Pediatric Master Protocol Development
The Role of In Vitro Diagnostic Tests in Pediatric Master Protocol Development September 23, 2016 Anand Pathak, MD, PhD, MPH Medical Officer Molecular Genetics Branch Division of Molecular Genetics and
More informationTumorNext-HR D. patient guide. a test for ovarian cancer patients to identify hereditary and tumor-specific mutations
patient guide TumorNext-HR D a test for ovarian cancer patients to identify hereditary and tumor-specific mutations Because knowing can mean personalized treatment and management Germline vs. Tumor Testing
More informationDNA is the genetic material that provides instructions for what our bodies look like and how they function. DNA is packaged into structures called
DNA is the genetic material that provides instructions for what our bodies look like and how they function. DNA is packaged into structures called chromosomes. We have 23 pairs of chromosomes (for a total
More informationA Guide for Understanding Genetics and Health
Does it Run in the Family? A Guide for Understanding Genetics and Health lesbian & gay family building project Contents Why is genetics important to my family and me? 1 What makes me unique? 2 Tell me
More informationIllumina Clinical Services Laboratory
Illumina Clinical Services Laboratory Illumina, Inc. 5200 Illumina Way San Diego, CA 92122, USA Phone: 858.736.8080 Fax: 858.255.5285 everygenome@illumina.com CLIA Certificate No.: 05D1092911 Illumina
More informationLearn your genetic risk for the most common hereditary cancers.
Learn your genetic risk for the most common hereditary cancers. color.com Color analyzes 30 genes including BRCA1 and BRCA2 to help women and men understand their risk for the most common hereditary cancers,
More informationApplications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns
Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns جواد کریمزاد حق PhD of Medical Genetics آزمايشگاه پاتوبيولوژي و ژنتيك پارسه
More informationUsing the Bravo Liquid-Handling System for Next Generation Sequencing Sample Prep
Using the Bravo Liquid-Handling System for Next Generation Sequencing Sample Prep Tom Walsh, PhD Division of Medical Genetics University of Washington Next generation sequencing Sanger sequencing gold
More informationAbstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction
Optimization strategy of Copy Number Variant calling using Multiplicom solutions Michael Vyverman, PhD; Laura Standaert, PhD and Wouter Bossuyt, PhD Abstract Copy number variations (CNVs) represent a significant
More informationSo, now, that we have reviewed some basics of cancer genetics I will provide an overview of some common syndromes.
Hello. My name is Maureen Mork and I m a Certified Genetic Counselor in the Clinical Cancer Genetics Program at The University of Texas MD Anderson Cancer Center. I ll be lecturing today on the Cancer
More informationAnalysis with SureCall 2.1
Analysis with SureCall 2.1 Danielle Fletcher Field Application Scientist July 2014 1 Stages of NGS Analysis Primary analysis, base calling Control Software FASTQ file reads + quality 2 Stages of NGS Analysis
More informationAdvance Your Genomic Research Using Targeted Resequencing with SeqCap EZ Library
Advance Your Genomic Research Using Targeted Resequencing with SeqCap EZ Library Marilou Wijdicks International Product Manager Research For Life Science Research Only. Not for Use in Diagnostic Procedures.
More informationPersonalis ACE Clinical Exome The First Test to Combine an Enhanced Clinical Exome with Genome- Scale Structural Variant Detection
Personalis ACE Clinical Exome The First Test to Combine an Enhanced Clinical Exome with Genome- Scale Structural Variant Detection Personalis, Inc. 1350 Willow Road, Suite 202, Menlo Park, California 94025
More informationGenetic testing for hereditary cancer. An overview for healthcare providers
Genetic testing for hereditary cancer An overview for healthcare providers Specimen requirements Whole blood Two 4.5 ml EDTA tubes (lavender top) Please wait at least 2 weeks after a packed cell/platelet
More informationSporadic Cancer - Cancer which occurs by chance. People with sporadic cancer typically do not have relatives with the same type of cancer.
to risk assessment Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary cancer testing is right for you and should be reviewed with a trained healthcare
More informationLIPITOR AND YOU HELPFUL INFORMATION FOR UNDERSTANDING CHOLESTEROL AND RISKS
LIPITOR AND YOU HELPFUL INFORMATION FOR UNDERSTANDING CHOLESTEROL AND RISKS Learn what your cholesterol levels actually mean, and how you may save money on your prescription each month with the LIPITOR
More informationA Guide for Understanding Genetics and Health
2 Does it Run in the Family? A Guide for Understanding Genetics and Health the genomedical connection Contents Why is genetics important to my family and me? 1 What makes me unique? 2 Tell me more about
More informationNGS Gateway Lab Services
TM NGS Gateway Lab Services Accelerating Precision Medicine Design a Complete Genomic Testing Portfolio with Turnkey Assays About NGS Gateway Lab Services TM Designed to provide a gateway to your own in-house
More informationInvestigating rare diseases with Agilent NGS solutions
Investigating rare diseases with Agilent NGS solutions Chitra Kotwaliwale, Ph.D. 1 Rare diseases affect 350 million people worldwide 7,000 rare diseases 80% are genetic 60 million affected in the US, Europe
More informationSharan Goobie, MD, MSc, FRCPC
Sharan Goobie, MD, MSc, FRCPC Chromosome testing in 2014 Presenter Disclosure: Sharan Goobie has no potential for conflict of interest with this presentation Objectives Review of standard genetic investigations
More informationGENETIC TESTING AND COUNSELING FOR HERITABLE DISORDERS
Status Active Medical and Behavioral Health Policy Section: Laboratory Policy Number: VI-09 Effective Date: 03/17/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members
More informationVanderbilt University Institutional Review Board Informed Consent Document for Research. Name of participant: Age:
This informed consent applies to: Adults Name of participant: Age: The following is given to you to tell you about this research study. Please read this form with care and ask any questions you may have
More informationCNNH NeuroGenomics Program Peer-to-Peer Service Consent/Information Form
CNNH NeuroGenomics Program Peer-to-Peer Service Consent/Information Form WHO WEARE The Center for Neurological and Neurodevelopmental Health (CNNH) is an innovative patient- and family-centered "Specialty
More informationNGS for Cancer Predisposition
NGS for Cancer Predisposition Colin Pritchard MD, PhD University of Washington Dept. of Lab Medicine AMP Companion Society Meeting USCAP Boston March 22, 2015 Disclosures I am an employee of the University
More informationCancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor
Cancer Survivorship Symposium Cancer and Heredity January 16, 2017 Jeanne P. Homer, MS Licensed Certified Genetic Counselor Outline Cancer and Heredity Hereditary Cancer Risk Assessment & Genetic testing
More informationAdenomatous Polyposis Syndromes (FAP/AFAP and MAP)
A Patient s Guide to risk assessment Adenomatous Polyposis Syndromes (FAP/AFAP and MAP) Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary cancer
More informationPALB2 c g>c is. VARIANT OF UNCERTAIN SIGNIFICANCE (VUS) CGI s summary of the available evidence is in Appendices A-C.
Consultation sponsor (may not be the patient): First LastName [Patient identity withheld] Date received by CGI: 2 Sept 2017 Variant Fact Checker Report ID: 0000001.5 Date Variant Fact Checker issued: 12
More informationBRCA 1/2. Breast cancer testing THINK ABOUT TOMORROW, TODAY
BRCA 1/2 Breast cancer testing THINK ABOUT TOMORROW, TODAY 5 10% of patients with breast and/or ovarian cancer have a hereditary form1. For any individual carrying a mutation in BRCA1 or BRCA2, the lifetime
More informationA Guide for Understanding Genetics and Health
2 D o e s i t Ru n i n t h e Fa m i ly? A Guide for Understanding Genetics and Health Institute for Cultural Partnerships Contents Why is genetics important to my family and me? 1 What makes me unique?
More informationCytogenetics 101: Clinical Research and Molecular Genetic Technologies
Cytogenetics 101: Clinical Research and Molecular Genetic Technologies Topics for Today s Presentation 1 Classical vs Molecular Cytogenetics 2 What acgh? 3 What is FISH? 4 What is NGS? 5 How can these
More informationAdenomatous Polyposis Syndromes (FAP/AFAP and MAP)
A Patient s Guide to risk assessment Adenomatous Polyposis Syndromes (FAP/AFAP and MAP) Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary cancer
More informationTelephone Disclosure Visual Aid Toolkit: Panel Testing
Telephone Disclosure Visual Aid Toolkit: Panel Testing This is your visual aid toolkit that will be used during your disclosure appointment. Included in this packet are definitions and descriptions of
More informationAssessing Laboratory Performance for Next Generation Sequencing Based Detection of Germline Variants through Proficiency Testing
Assessing Laboratory Performance for Next Generation Sequencing Based Detection of Germline Variants through Proficiency Testing Karl V. Voelkerding, MD Professor of Pathology University of Utah Medical
More informationA Patient s Guide to. Hereditary Ovarian Cancer: Is Hereditary Cancer Testing Right for You?
A Patient s Guide to Hereditary Ovarian Cancer: Is Hereditary Cancer Testing Right for You? What is Hereditary Cancer? Most cancers occur in people who do not have a strong family history of that cancer.
More informationLaboratory Service Report
Client C7028846-DLP Rochester Rochester, N 55901 Specimen Type Peripheral blood CR PDF Report available at: https://test.mmlaccess.com/reports/c7028846-zwselwql7p.ashx Indication for Test DS CR Pathogenic
More informationCorporate Medical Policy Genetic Testing for Breast and Ovarian Cancer
Corporate Medical Policy Genetic Testing for Breast and Ovarian Cancer File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_breast_and_ovarian_cancer 8/1997 8/2017
More informationMutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research
Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research Application Note Authors John McGuigan, Megan Manion,
More informationDO YOU HAVE A FAMILY HISTORY OF ONE OF THESE CANCERS? BREAST, OVARIAN, COLORECTAL, ENDOMETRIAL, PANCREAS, PROSTATE, STOMACH OR SKIN CANCERS?
DO YOU HAVE A FAMILY HISTORY OF ONE OF THESE CANCERS? BREAST, OVARIAN, COLORECTAL, ENDOMETRIAL, PANCREAS, PROSTATE, STOMACH OR SKIN CANCERS? IF SO, ASK YOUR DOCTOR IF THE PREVENTEST CAN HELP PREDICT YOUR
More informationGENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Shawnia Ryan, MS, LCGC Senior Genetic Counselor University of New Mexico Cancer Center
GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Shawnia Ryan, MS, LCGC Senior Genetic Counselor University of New Mexico Cancer Center What is genetic counseling? communication process address individual
More informationAVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits
AVENIO family of NGS oncology assays ctdna and Tumor Tissue Analysis Kits Accelerating clinical research Next-generation sequencing (NGS) has the ability to interrogate many different genes and detect
More informationDo You Know Your Cholesterol Levels? Healthy Hearts, Healthy Homes
Do You Know Your Cholesterol Levels? Healthy Hearts, Healthy Homes Read other booklets in the Healthy Hearts, Healthy Homes series: Are You at Risk for Heart Disease? Do You Need To Lose Weight? Keep the
More informationUnderstanding public and private genetic testing for cancer risk. Frequently asked questions
Understanding public and private genetic testing for cancer risk Frequently asked questions What is genetic testing for cancer risk? Certain gene faults (also called mutations or variants) increase the
More informationIBMPFD Educational Information For Patients and Families
Page 1 of 5 CLIA # 05D1034314 CA State License: CLF 332383 IBMPFD Educational Information For What is IBMPFD? IBMPFD stands for Inclusion Body Myopathy associated with Paget s disease of bone and/or Frontotemporal
More informationStructural Variation and Medical Genomics
Structural Variation and Medical Genomics Andrew King Department of Biomedical Informatics July 8, 2014 You already know about small scale genetic mutations Single nucleotide polymorphism (SNPs) Deletions,
More informationNEW GUIDELINES FOR CHOLESTEROL
NEW GUIDELINES FOR CHOLESTEROL NEW CHOLESTEROL GUIDELINES 2013 Recently updated guidelines for the treatment of high blood cholesterol levels is a major update since 2002. The news media have trumpeted
More informationGenomic structural variation
Genomic structural variation Mario Cáceres The new genomic variation DNA sequence differs across individuals much more than researchers had suspected through structural changes A huge amount of structural
More informationDoes Cancer Run in Your Family?
Does Cancer Run in Your Family? A Patient s Guide to Hereditary Breast and Ovarian Cancer Syndrome What is Hereditary Cancer? Most cancers occur in people who do not have a strong family history of that
More informationFamilial Hypercholesterolemia
Understanding (FH) Familial Hypercholesterolemia For more information, visit Understanding Familial Hypercholesterolemia (FH) Your doctor may have told you that too much of the bad type of cholesterol
More information3/6/2017-6/15/2017 Permission to Take Part in a Human Research Study Page 1 of 6
Permission to Take Part in a Human Research Study Page 1 of 6 University at Buffalo Institutional Review Board (UBIRB) Office of Research Compliance Clinical and Translational Research Center Room 5018
More informationCURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi
2 CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE Dr. Bahar Naghavi Assistant professor of Basic Science Department, Shahid Beheshti University of Medical Sciences, Tehran,Iran 3 Introduction Over 4000
More informationCANCER GENETICS PROVIDER SURVEY
Dear Participant, Previously you agreed to participate in an evaluation of an education program we developed for primary care providers on the topic of cancer genetics. This is an IRB-approved, CDCfunded
More informationpatient guide MelanomaNext genetic testing for hereditary melanoma Because knowing your risk can mean early detection and prevention
patient guide MelanomaNext genetic testing for hereditary melanoma Because knowing your risk can mean early detection and prevention Know the Basics The average age of diagnosis for melanoma is 63 YEARS
More informationTalking Genomes with Your Patients. Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology
Talking Genomes with Your Patients Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology Objectives Review the importance of physician familiarity with genomic testing
More informationHereditary Cardiovascular Conditions
patient guide Hereditary Cardiovascular Conditions genetic testing for inherited cardiovascular diseases Finding answers quickly to help guide patient care Know the Basics 34 million people worldwide have
More informationBlood Types and Genetics
Blood Types and Genetics Human blood type is determined by codominant alleles. An allele is one of several different forms of genetic information that is present in our DNA at a specific location on a
More informationCorporate Medical Policy
Corporate Medical Policy Genetic Testing for Heterozygous Familial Hypercholesterolemia File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_ testing_ for_heterozygous_ familial_
More informationLynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP)
Lynch Syndrome (HNPCC) and MYH-Associated Polyposis (MAP) A Patient s Guide to risk assessment Hereditary Cancer Testing: Is it Right for You? This workbook is designed to help you decide if hereditary
More informationADDRESSING CHRONIC DISEASES
ADDRESSING CHRONIC DISEASES Health-Management Strategies for Use with Behavioral Health Clients Mary Brunette, MD Delia Cimpean Hendrick, MD SCOPE AND SEQUENCE For more information about this program,
More information